Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Rebound, Stratagene Shares Fall Again

Shares of Bruker Biosciences gained 13.4 percent for the trading week ended Tuesday, reversing a 7-percent decline the week before. The firm led the seven companies in the BCW Index that gained ground for the tracking period. Stratagene led decliners in the Index with a drop of 9.3 percent. Its shares reached a 52-week low of $5.51 on Tuesday before closing at $5.67.

Overall, the Index gained .1 percent for the week. In comparison, the Dow Jones Industrial Average fell .5 percent, the Nasdaq dropped .3 percent, and the Nasdaq Biotech Index declined .7 percent.

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(June 27, 2006)
Last
Price
(June 20, 2006)
% change
Agilent
A
30.44
32.18
-5.4
Applied Biosystems
ABI
32.15
30.50
5.4
Beckman
BEC
53.43
53.44
0.0
Bio-Rad
BIO
64.35
64.80
-0.7
Bruker
BRKR
5.24
4.62
13.4
Fisher Scientific
FSH
69.27
70.29
-1.5
GE
GE
32.88
33.70
-2.4
Harvard Bio
HBIO
4.31
4.09
5.4
Invitrogen
IVGN
64.89
64.19
1.1
Molecular Devices
MDCC
29.45
28.42
3.6
PerkinElmer
PKI
20.35
20.40
-0.2
Qiagen
QGEN
12.89
13.20
-2.3
Sigma
SIAL
70.70
70.03
1.0
Stratagene
STGN
5.67
6.25
-9.3
Thermo
TMO
34.03
34.82
-2.3
Waters
WAT
43.19
41.66
3.7
BCW Index Average
35.83
35.79
0.1
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.